Most G-protein-coupled receptors have conserved cysteine residues in their C-terminal cytoplasmic domain that appear to be generally palmitoylated. An example is the human arginine vasopressin V2 receptor with cysteine residues at positions 341 and 342. Site-directed mutagenesis of the putative palmitoylation site was used to study the significance of palmitoylation for the V2 receptor. A multifunctional expression plasmid was constructed by cloning the V2 receptor cDNA into the vector pCDNAI.Neo. The resulting plasmid allowed site-directed mutagenesis experiments without subcloning, and stable and transient expression of the V2 receptor in Ltk − and COS.M6 cells respectively. The conserved cysteine residues Cys-341 and Cys-342 were replaced by serine residues, yielding the single mutants C-341S and C-342S and the double mutant C-341S\C-342S. Functional expression in stably transfected Ltk − cells showed that the affinity of the three mutant receptors for arginine vasopressin was not altered. In contrast with the activation of
INTRODUCTION
Binding of 8-arginine vasopressin (AVP, antidiuretic hormone, ADH) to V2 vasopressin receptors activates the G s \adenylate cyclase system of renal collecting duct epithelial cells. The increase in cAMP leads to the insertion of water channels (aquaporins) into the cell membrane (for a review see [1] ). As a consequence, the water permeability of the cell membrane is dramatically enhanced, allowing reabsorption of water (antidiuretic effect).
Molecular cloning and sequencing of the cDNAs encoding human and rat V2 receptors revealed structural features common to the large family of G-protein-coupled receptors, such as a heptahelical transmembrane organization, an extracellular Nterminus and an intracellular C-terminus [2, 3] . The C-terminal cytoplasmic domain of the V2 receptor contains two adjacent cysteine residues (Cys-341 and Cys-342). The corresponding cysteine residues of the rat luteinizing hormone\human choriogonadotropin receptor (LH\hCG receptor) [4] and of bovine rhodopsin [5, 6] are known to be palmitoylated. In other receptors, the C-terminal domain possesses only one corresponding cysteine residue, which was found to be palmitoylated in the β # adrenergic receptor [7] and in the α #A adrenergic receptor [8] . It is generally assumed that all G-protein-coupled receptors with cysteine residues at an appropriate distance from the seventh transmembrane helix are palmitoylated at these sites. Direct demonstration of V2 receptor palmitoylation is currently complicated Abbreviations used : AVP, 8-arginine vasopressin ; D-PBS, Dulbecco's PBS ; DMEM, Dulbecco's modified Eagle's medium ; G418, Geniticin 418 ; LH/hCG receptor, luteinizing hormone/human choriogonadotropin receptor ; TRH receptor, thyrotropin-releasing hormone receptor.
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adenylate cyclase through β # adrenergic receptors, arginine vasopressin stimulated adenylate cyclase to the same extent and with similar EC &! values in both wild-type and mutant receptors. Transient expression of the C-341S\C-342S mutant receptor in COS.M6 cells confirmed an unaltered affinity of the mutant receptor for arginine vasopressin. However, the number of arginine vasopressin-binding sites on the cell surface was reduced by 30 %, suggesting that the transport of the mutant receptor to the cell surface was impaired. In addition, the decrease in detectable arginine vasopressin-binding sites on the cell surface following pre-exposure to hormone was reduced, indicating that the sequestration\internalization of the mutant receptor on the cell surface was affected. The present data indicate that palmitoylation of the V2 receptor is important for intracellular trafficking and\or sequestration\internalization but not for agonist binding or activation of the G s \adenylate cyclase system. by the lack of specific antibodies and by the fact that insufficient amounts of recombinant receptor protein can be expressed.
It is believed that the palmitate tails serve to attach the Ctermini of the receptors to the membrane, but conflicting results have been obtained regarding the functional consequences of such a modification. With the help of site-directed mutagenesis experiments, palmitoylation was shown to be necessary for both coupling of the β # adrenergic receptor to G s [7] and for long-term down regulation of the α #A adrenergic receptor [9] . Furthermore, palmitoylation-deficient LH\hCG receptors were internalized more rapidly than wild-type receptors following exposure to agonist [4] , whereas non-palmitoylated thyrotropin-releasing hormone receptors (TRH receptors) were internalized at slower rates [10] . The data suggest a role for the fatty acids in sequestration\internalization of receptors. The present results indicate that palmitoylation may serve different functions in different receptor\G-protein systems. We have replaced the conserved cysteine residues of the human V2 receptor with serine residues and assessed the functional consequences.
MATERIAL AND METHODS

Materials
Escherichia coli strains, phages and eukaryotic cell lines are listed in Table 1 , and nucleic acids are listed in Table 2 . 
[$H]AVP
Cell culture
Ltk − and COS.M6 cells were cultured at 5 % CO # in DMEM containing 10 % (v\v) heat-inactivated fetal bovine serum, penicillin (100 units\ml) and streptomycin (100 µg\ml). For culture of stably transfected Ltk − cells, the medium was supplemented with G418 (400 µg\ml).
DNA manipulations
Standard DNA preparations and manipulations were carried out according to the handbooks of Sambrook et al. [11] and Perbal [12] . The nucleotide sequences of DNA fragments were de- termined using the Sequenase plasmid sequencing kit from United States Biochemical (Cleveland, OH, U.S.A.).
Construction of an expression plasmid for the V2 receptor cDNA and site-directed mutagenesis
The original cDNA of the V2 receptor [13] was PCR amplified with primers introducing EcoRI (5h) and BamHI (3h) sites respectively (see Table 2 ) and removing the bulk of the 5h-and 3h-non-coding regions. For reasons that are not relevant for this paper, the EcoRI\BamHI-cut PCR fragment was first cloned into the EcoRI\BglII-cut baculovirus transfer vector pBacPAK9. From the resulting plasmid, the V2 receptor cDNA was excised as a BamHI-XbaI fragment and cloned into the BamHI\XbaI-cut vector pCDNAI.Neo, yielding pRCDN2 ( Figure 1 ). Construction of pRCDN2 was carried out in the host strain E. coli MC1061\P3.
The entire V2 receptor cDNA insert was sequenced to verify its composition. The plasmid was used for site-directed mutagenesis and for transient and stable expression in COS.M6 and Ltk − cells respectively (see below). For mutagenesis of the putative palmitoylation site, pRCDN2 was transformed into the Fh-strain E. coli BMH71-18. Single-stranded DNA of pRCDN2 was isolated with M13K07 helper phage. Mutagenesis was carried out with the T7-Gen in itro mutagenesis kit (United States Biochemical, Cleveland, OH, U.S.A.) using E. coli SDM2 as host strain. In the mutagenesis experiments, cysteine residues 341 and 342 were replaced by serine residues, yielding the single mutants C-341S and C-342S and the double mutant C-341S\C-342S. The mutant plasmids were identified by both their novel restriction sites (EspI for C-341S and C-341S\C-342S, PstI for C-342S ; for primer sequences see Table 2 ) and by DNA sequencing.
Transient expression of wild-type and mutant V2 receptors in COS.M6 cells
For transfection of COS.M6 cells, the lipid-mediated DNAtransfection procedure [14] was used. Lipofectin (7.5 µl) was diluted in 100 µl of serum-free medium and mixed with 0.5 µg of plasmid DNA in 100 µl of serum-free medium. The mixture was incubated for 15 min at room temperature and diluted with 0.8 ml of serum-free medium. COS.M6 cells (9i10%) in a 35-mm-diam. dish were washed twice with serum-free medium and subsequently incubated with the DNA\liposome mixture. After 20 h of incubation, the serum-free medium was exchanged for 2 ml of complete medium. Cells were incubated for 3 days and then assayed for [$H]AVP binding.
Stable expression of wild-type and mutant V2 receptors in Ltk − cells
Ltk − cells (2i10&) were transfected with 2 µg of plasmid DNA in a 60-mm-diam. dish as described above. After 2 days of incubation in complete medium, cells were diluted 5-fold with medium containing G418 (400 µg\ml) and spread on 60-mmdiam. dishes to select for resistant cells. For the wild-type and each mutant receptor, 20 individual clones were isolated, expanded and screened for functional expression of the V2 receptor on the basis of specific [$H]AVP binding to intact cells. Only those clones expressing more than 50 000 receptor sites per cell were used for further studies.
[ 3 H]AVP binding assay
The procedure described previously [13, 15] was essentially followed. Transfected COS.M6 or Ltk − cells in 35-mm-diam. dishes were washed twice with 2 ml of binding buffer consisting of Dulbecco's PBS (D-PBS) (0.9 mM CaCl # \0.5 mM MgCl # \ 2.7 mM KCl\136.9 mM NaCl\1.5 mM KH # PO % \8.1 mM Na # HPO % , pH 7.4) supplemented with 180 ng\ml tyrosine, 165 ng\ml phenylalanine, 1 mg\ml glucose and 20 mg\ml BSA.
[$H]AVP, diluted in 1 ml of the same buffer, was added to achieve the indicated concentrations. Non-specific binding was determined in the presence of 10 µM unlabelled AVP. Cells were incubated with the hormone for 2 h on ice (to avoid receptor internalization) and washed quickly three times with ice-cold D-PBS, lysed with 1 ml of 0.1 M NaOH and held at room temperature for 30 min. The fluid was transferred to scintillation vials containing 3.5 ml of scintillant. Radioactivity was determined with a liquid scintillation counter.
For desensitization studies, COS.M6 cells in 35-mm-diam. dishes were transfected with plasmid DNA as described above. After 3 days of incubation in complete medium, AVP (100 nM) was added, and the cells were further incubated for different times at 37 mC. Desensitizing treatments were terminated by washing the cells with 2 ml of ice-cold 5 mM acetic acid in isotonic saline solution [13] . 
Adenylate cyclase activity assay
Preparation of nuclei-free crude membrane fractions and the adenylate cyclase assay were as described previously [13] .
[$#P]cAMP was isolated according to the two-column method [16] .
RESULTS
Elimination of the putative palmitoylation site does not alter the affinity of the V2 receptor for AVP
Cell lines derived from Ltk − cells expressing wild-type and mutant receptors were tested for agonist binding. Representative 
H]AVP binding profiles of Ltk − cell-derived clones stably expressing the wild-type V2 receptor and the mutants C-341S/C-342S, C-341S and C-342S
Data points for specific and unspecific binding of 
Figure 3 Adenylate cyclase assay of Ltk − cell-derived clones stably expressing the wild-type V2 receptor and the mutants C-341S/C-342S, C-341S and C-342S
Adenylate cyclase activity was determined in a crude membrane preparation. Data are calculated as the percentage of activity following maximal prostaglandin E 1 (PGE 1 [$H]AVP binding to intact cells expressing the wild-type and the three mutant receptors were indistinguishable within the experimental error, ranging from 1.0 to 1.6 nM. These results indicate that palmitoylation of the V2 receptor is not relevant for agonist binding. For all clones, the number of AVP receptors was well above the critical value (28 000 per cell) required for
Figure 4 Comparison of specific [ 3 H]AVP binding to intact COS.M6 cells expressing the wild-type V2 receptor or the double mutant C-341S/C-342S
Data points for specific binding of maximal activation of the G s \adenylate cyclase system of Ltk − cells [15] .
The putative palmitoylation site is not required for efficient coupling to the G s /adenylate cyclase system
Previous studies have revealed that non-palmitoylated β # adrenergic receptors lose guanyl nucleotide sensitivity of agonist binding and show a 70 % reduced ability to stimulate adenylate cyclase [7] . To examine whether the latter holds true for the V2 receptor, membranes of cell lines expressing wild-type and mutant receptors were prepared and AVP-sensitive adenylate cyclase activity was measured (Figure 3) . For comparison of different cell clones, enzyme activity was expressed as the percentage of maximal response to prostaglandin E " , which activates the G s \adenylate cyclase system of Ltk − cells through endogenous prostaglandin E " receptors [15] . The extent of adenylate cyclase stimulation was similar in all clones. The EC &! values of the mutants C-341S (10 nM) and C-341S\C-342S (14 nM) were slightly higher than those of the wild-type receptor (2 nM) and the mutant C-342S (4 nM) (see Figure 3) . These minor differences may reflect differences in the number of receptors per cell. The results suggest that, in contrast with the palmitate modifications of the β # adrenergic receptor, the putative palmitoylation of the V2 receptor does not have a major effect on the activation of the G s \adenylate cyclase system.
Elimination of the putative palmitoylation site decreases the number of detectable cell-surface receptors
The selection procedure for identification of V2 receptor-expressing clones precludes the possibility of assessing the effect of a given mutation on cell-surface expression of receptors. To avoid clonal influence, the presence of V2 receptor mutants on the cell surface was examined in COS.M6 cells transiently expressing V2 receptors after transfection with recombinant plasmids. To this end, COS.M6 cells transfected with equal amounts of wild-type and C-341S\C-342S plasmid DNA were assayed for their capacity to bind [$H]AVP (Figure 4 ). Similar to 
H]AVP-binding sites on COS.M6 cells expressing the wild-type V2 receptor or the double mutant C-341S/C-342S
Cells were preincubated for the indicated times with 100 nM AVP at 37 mC, and residual binding capacity for The data are consistent with a decreased delivery of the double-mutant receptor to the cell membrane or an increased rate of sequestration\internalization.
Elimination of the putative palmitoylation site delays agonistinduced loss of detectable cell-surface receptors
Previous studies have shown that agonist-induced desensitization of the V2 receptor is accompanied by a rapid loss of detectable AVP binding sites on the cell surface, presumably resulting exclusively from internalization [13] . To examine whether the reduced number of double-mutant receptors can be explained by an increased rate of sequestration\internalization, AVP-induced loss of [$H]AVP binding to COS.M6 cells expressing wild-type and mutant receptors was measured. Cells were preincubated with non-labelled AVP (100 nM) for 5 min-24 h at 37 mC, hormone was removed by acid washes, and residual binding capacity was determined with [$H]AVP to estimate the number of receptors remaining on the cell surface ( Figure 5 ). The experiment confirmed previously published data that the apparent loss of wild-type receptor from the cell surface is a rapid process that is more than 80 % complete within 5 min [13] . After 30 min of preincubation with AVP, only 15 % of initially measured wild-type receptors were detectable. Surprisingly, the rate of loss of the mutant receptor was reduced over a period of at least 4 h to approx. 50 % of that of the wild type. For example, after 30 min of preincubation with AVP, about 35 % of the initially determined cell-surface receptors were still present. No difference between wild-type and mutant receptors was found after preincubation with AVP for 24 h (9-10 % and 6-9 % of the initially detected binding sites were still present on cells expressing wild-type and mutant receptors respectively). These results suggest that the double-mutant receptor cannot be internalized\ sequestered as efficiently as the wild-type receptor, when occupied by agonist.
DISCUSSION
We have eliminated the putative palmitoylation site of the human V2 vasopressin receptor to assess the functional consequences of this post-translational modification. Our results indicate that palmitoylation does not influence agonist binding. Except for the β # adrenergic receptor [7] , the same was observed for all G-protein-coupled receptors so far examined. Furthermore, palmitoylation of the V2 receptor is apparently not necessary for full activation of the G s \adenylate cyclase system. The minimal right-shift of the dose-response curves of mutants C-341S and C-341S\C-342S may reflect the relatively low number of receptors per cell or a slight aberration in overall receptor folding rather than specific impairment of coupling to G s in the absence of palmitate side chains. Our results are by no means comparable with the dramatic decrease in adenylate cyclase stimulation observed with the non-palmitoylated β # adrenergic receptor [7] . Instead, they agree with previous work that demonstrated the independence from palmitoylation of the signaltransducing properties of the m # muscarinic receptor [17] , α #A adrenergic receptor [8, 9] , rhodopsin [18] , TRH receptor [10] and LH\hCG receptor [4] .
In COS.M6 cells expressing the double mutant C-341S\ C-342S, the number of receptors detectable on the cell surface reaches only 70 % of the wild-type level (Figure 4) , as previously observed for the non-palmitoylated LH\hCG receptor [4] . An impaired membrane insertion can be excluded because palmitoylation takes place in the cis-Golgi cisternae after insertion in the membrane of the endoplasmic reticulum [19] . Therefore the reduced number of detectable binding sites could result from a decreased transport from the trans-Golgi cisternae to the surface or an increased sequestration\internalization of mutant receptors. Since changes in transcription or translation efficiency cannot be excluded, it also remains possible that the total amount of receptor is lower in cells expressing the mutant as opposed to cells expressing the wild-type receptor.
Recently published data show that palmitoylation-deficient LH\hCG receptors are internalized at higher rates than wildtype receptors [4] . In contrast with these data, the loss of detectable AVP-binding sites following agonist incubation was decreased in COS.M6 cells transiently expressing the mutant C-341S\C-342S, suggesting that sequestration\internalization of the mutant V2 receptor was delayed rather than accelerated. Our results agree with the reduced internalization rate of the palmitoylation-defective TRH receptor, which was only 50 % of that of the wild-type receptor [10] .
In summary, V2 receptors with an eliminated putative palmitoylation site appear to be impaired in two related respects : those of transport to and rate of agonist-induced removal from the cell surface. A plausible explanation for this phenomenon would be that palmitate modifications are a signal for the vesicleforming machinery or vesicle budding [19] . Alternatively, the fatty acids could be necessary to promote C-terminal conformations of G-protein-coupled receptors that interact with other components of the vesicular transport system.
